Long-term remission of an AIDS-related primary effusion lymphoma with antiviral therapy.
about
Targeting KSHV/HHV-8 latency with COX-2 selective inhibitor nimesulide: a potential chemotherapeutic modality for primary effusion lymphomaTargeting sphingosine kinase induces apoptosis and tumor regression for KSHV-associated primary effusion lymphoma.Systematic analysis of a xenograft mice model for KSHV+ primary effusion lymphoma (PEL)Cooperative roles for emmprin and LYVE-1 in the regulation of chemoresistance for primary effusion lymphoma.Kaposi sarcoma-associated herpesvirus (KSHV): molecular biology and oncogenesisTreatment of Kaposi sarcoma-associated herpesvirus-associated cancers.Therapeutic options for human herpesvirus-8/Kaposi's sarcoma-associated herpesvirus-related disorders.Antitumour effects of antiretroviral therapy.Comparison of human herpes virus 8 related primary effusion lymphoma with human herpes virus 8 unrelated primary effusion lymphoma-like lymphoma on the basis of HIV: report of 2 cases and review of 212 cases in the literature.Primary effusion lymphoma diagnosed by pericardiocentesis.New approaches to the treatment of human herpesvirus 8-associated disease.Targeted therapy for Kaposi sarcoma.Use of cidofovir for the treatment of HIV-negative human herpes virus-8-associated primary effusion lymphoma.Therapeutic options for HIV-associated lymphomas.New drug targets in Kaposi sarcoma.Regression of HIV-associated grade IV T cell lymphoma with combined antiretroviral therapy only.Human herpesvirus 8-associated neoplasms: the roles of viral replication and antiviral treatment.Primary effusion lymphoma in an elderly patient effectively treated by lenalidomide: case report and review of literature.Current status of treatment for primary effusion lymphoma.KSHV targeted therapy: an update on inhibitors of viral lytic replication.Clinical management of HIV-associated hematologic malignancies.STAT3 Regulates Lytic Activation of Kaposi's Sarcoma-Associated Herpesvirus.Concurrent targeting of eicosanoid receptor 1/eicosanoid receptor 4 receptors and COX-2 induces synergistic apoptosis in Kaposi's sarcoma-associated herpesvirus and Epstein-Barr virus associated non-Hodgkin lymphoma cell lines.Multiple viral infections in primary effusion lymphoma: a model of viral cooperation in lymphomagenesis.Primary Effusion Lymphoma: Is Dose-Adjusted-EPOCH Worthwhile Therapy?Oncolytic Reactivation of KSHV as a Therapeutic Approach for Primary Effusion Lymphoma.Head and Neck Lymphomas in HIV Patients: a Clinical Perspective.Primary effusion lymphoma involving three body cavitiesIs it now the time to update treatment protocols for lymphomas with new anti-virus systems?Kaposi's sarcoma herpesvirus lytic replication compromises apoptotic response to p53 reactivation in virus-induced lymphomas.Case report of a primary effusion lymphoma successfully treated with oral valganciclovir after failing chemotherapy.Primary effusion lymphoma: current perspectives.FUS Negatively Regulates Kaposi's Sarcoma-Associated Herpesvirus Gene Expression
P2860
Q21135231-DDC4A9E5-C054-4311-9834-615520475A25Q30408885-5C5A06F1-ABC0-4242-87E6-8AEB5CAD7746Q30414412-B65D5C36-E09A-42A3-8360-930D467118B8Q30418735-3A95051B-7CF7-4808-9935-CD0353056257Q35127940-1AE0FC90-D3E7-453C-A548-B1DD5A5DBFF4Q35895560-2C46E7AD-D835-476F-A848-7FDF720593DCQ35917368-E11FE977-D211-44E5-8304-27AEE23A5232Q35934144-CF00FB27-3AA3-4ABF-95F5-BAF5A45C9976Q36668747-25264BB4-1C5E-4223-9EBB-8D819113A30DQ37061042-171C0A47-4BEF-445F-A36F-B7405D520A29Q37211987-C7A26CB2-CA06-41D7-BAF9-2C9B104E3E3EQ37505000-D802E79C-ECF5-4931-8878-AA2136FC0E68Q37765465-1E9E5BA9-9F1E-4446-9F43-79641878B629Q37781368-C0FE0CE8-4254-4EA6-BF34-6A88CB80CEC0Q37806235-925A2A68-3B4F-4DED-8E69-A515C00BE0B9Q37873828-50AE926D-D57F-4560-8FB2-CF8CB34B02FAQ37888397-2011AAC7-66AD-408B-B55A-8F7A7E994232Q38194434-33A8623B-327E-4927-9FF4-03269F7443C0Q38264454-CAFA6A84-DC8A-4A92-990A-27C09A033E30Q38271135-990A4D04-AF9D-4737-B3D3-656F9F798E65Q38664912-3A814FFB-B32F-4CE7-B3A8-1CF6584910FAQ38838049-22D3F400-5EA1-4AD9-BBE2-26B30ABC6487Q39176686-7C305375-447E-40DD-9D56-0F886008737EQ39281253-5183203C-66BF-452D-A4F0-426FC97CDF0EQ39555886-A3D10015-F39F-4F53-9FFE-90E7BC0DCF5EQ40067410-273DD4F9-D0B0-41C7-9BA6-3FBCD3B35367Q41919568-192B46C4-6500-48E3-BE32-B84A619A7A94Q42087566-7B182C1C-1E82-47B5-8909-5E299E7FFD06Q42986624-43E2B94B-981C-4A9A-B811-47DB789F6A30Q45358610-D4300276-1F27-4C29-BC96-643A67CD5A15Q48330061-F1D2AC12-7F83-4978-97E5-0C5B267AC98AQ55518093-E72D6804-FC0E-42E0-B676-88793CC7B167Q57029061-C9EA70A5-9D7C-4F41-9507-E3B27CA6DCA5
P2860
Long-term remission of an AIDS-related primary effusion lymphoma with antiviral therapy.
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Long-term remission of an AIDS-related primary effusion lymphoma with antiviral therapy.
@ast
Long-term remission of an AIDS-related primary effusion lymphoma with antiviral therapy.
@en
type
label
Long-term remission of an AIDS-related primary effusion lymphoma with antiviral therapy.
@ast
Long-term remission of an AIDS-related primary effusion lymphoma with antiviral therapy.
@en
prefLabel
Long-term remission of an AIDS-related primary effusion lymphoma with antiviral therapy.
@ast
Long-term remission of an AIDS-related primary effusion lymphoma with antiviral therapy.
@en
P2093
P1433
P1476
Long-term remission of an AIDS-related primary effusion lymphoma with antiviral therapy.
@en
P2093
E Oksenhendler
F Agbalika
J M Molina
L Hocqueloux
P304
P356
10.1097/00002030-200101260-00023
P407
P577
2001-01-01T00:00:00Z